Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 4

Therapeutics and Clinical Risk Management


Archive: Volume 3, 2007


Evaluation of patient care interventions and recommendations by a transitional care pharmacist

K Bruce Bayley, Lucy A Savitz, Teresa Maddalone, Stephen E Stoner, Jacquelyn S Hunt, Robert Wells

Therapeutics and Clinical Risk Management 2007, 3:695-703

Published Date: 15 September 2007

Ondansetron oral disintegrating tablets for the prevention of postoperative vomiting in children undergoing strabismus surgery

Deborah S Wagner, Virginia Gauger, Devi Chiravuri, Kristin Faust

Therapeutics and Clinical Risk Management 2007, 3:691-694

Published Date: 15 September 2007

How should we measure medication adherence in clinical trials and practice?

Jeannie K Lee, Karen A Grace, Terri G Foster, Monica J Crawley, Goldina I Erowele, et al

Therapeutics and Clinical Risk Management 2007, 3:685-690

Published Date: 15 September 2007

A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD)

Evangelos Kalaitzakis, Einar Björnsson

Therapeutics and Clinical Risk Management 2007, 3:653-663

Published Date: 15 September 2007

Review of tipranavir in the treatment of drug-resistant HIV

Hendrik Streeck, Jürgen Kurt Rockstroh

Therapeutics and Clinical Risk Management 2007, 3:641-651

Published Date: 15 September 2007

Prevention of shingles: safety and efficacy of live zoster vaccine

Dianna Quan, Randall J Cohrs, Ravi Mahalingam, Donald H Gilden

Therapeutics and Clinical Risk Management 2007, 3:633-639

Published Date: 15 September 2007

Using risk management files to identify and address causative factors associated with adverse events in pediatrics

Paul D Hain, James W Pichert, Gerald B Hickson, Sandra H Bledsoe, David Hamming, et al

Therapeutics and Clinical Risk Management 2007, 3:625-631

Published Date: 15 September 2007

A review of the use of adapalene for the treatment of acne vulgaris

Suleyman Piskin, Erol Uzunali

Therapeutics and Clinical Risk Management 2007, 3:621-624

Published Date: 15 September 2007

A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma

Gennaro D’Amato, Antonello Salzillo. Amedeo Piccolo, Maria D’Amato, Gennaro Liccardi

Therapeutics and Clinical Risk Management 2007, 3:613-619

Published Date: 15 September 2007

Clinical studies with oral lipid based formulations of poorly soluble compounds

Dimitrios G Fatouros, Ditte M Karpf, Flemming S Nielsen, Anette Mullertz

Therapeutics and Clinical Risk Management 2007, 3:591-604

Published Date: 15 September 2007

Treatment of premenstrual dysphoric disorder (PMDD) with a novel formulation of drospirenone and ethinyl estradiol

Domenico De Berardis, Nicola Serroni, Rosa Maria Salerno, Filippo Maria Ferro

Therapeutics and Clinical Risk Management 2007, 3:585-590

Published Date: 15 September 2007

The renaissance of fixed dose combinations: Combivir

Simon D Portsmouth, Christopher J Scott

Therapeutics and Clinical Risk Management 2007, 3:579-583

Published Date: 15 September 2007

Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results

Marco Metra, Savina Nodari, Tania Bordonali, Patrizia Milani, Carlo Lombardi, et al

Therapeutics and Clinical Risk Management 2007, 3:569-578

Published Date: 15 September 2007

Reflections on adjuvant treatment of gastric cancer

Albert Abad, José Luis Manzano, Cristina Martí

Therapeutics and Clinical Risk Management 2007, 3:563-567

Published Date: 15 September 2007

Lenalidomide: a brief review of its therapeutic potential in myelodysplastic syndromes

Aristoteles A N Giagounidis, Ulrich Germing, Sabine Haase, Carlo Aul

Therapeutics and Clinical Risk Management 2007, 3:553-562

Published Date: 15 September 2007

Review of thalidomide in the treatment of newly diagnosed multiple myeloma

Federica Cavallo, Mario Boccadoro, Antonio Palumbo

Therapeutics and Clinical Risk Management 2007, 3:543-552

Published Date: 15 September 2007

Current treatment options in the management of chronic prostatitis

Alain Jean Duclos, Chun-Te Lee, Daniel Arthur Shoskes

Therapeutics and Clinical Risk Management 2007, 3:507-512

Published Date: 15 September 2007

Editorial || FREE PAPER ||

Garry M Walsh

Therapeutics and Clinical Risk Management 2007, 3:505-506

Published Date: 15 September 2007